Peri-interventional use of rondaptivon pegol (BT200) in thrombocytopenic patients with type 2B von Willebrand disease with implications for wound healing and therapy for acute bleeding
Peri-interventional use of rondaptivon pegol (BT200) in thrombocytopenic patients with type 2B von Willebrand disease with implications for wound healing and therapy for acute bleeding. // Research and Practice in Thrombosis and Haemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S2475037926036745?dgcid=rss_sd_all
Peri-interventional use of rondaptivon pegol (BT200) in thrombocytopenic patients with type 2B von Willebrand disease with implications for wound healing and therapy for acute bleeding. Research and Practice in Thrombosis and Haemostasis. https://www.sciencedirect.com/science/article/pii/S2475037926036745?dgcid=rss_sd_all
“Peri-interventional use of rondaptivon pegol (BT200) in thrombocytopenic patients with type 2B von Willebrand disease with implications for wound healing and therapy for acute bleeding.” Research and Practice in Thrombosis and Haemostasis.
@article{article108548,
title = {Peri-interventional use of rondaptivon pegol (BT200) in thrombocytopenic patients with type 2B von Willebrand disease with implications for wound healing and therapy for acute bleeding},
journal = {Research and Practice in Thrombosis and Haemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S2475037926036745?dgcid=rss_sd_all}
}